19Due to its genetic amenability coupled with recent advances in genome editing, the zebrafish 20 serves as an excellent model to examine the function of both coding and non-coding elements. 21 Recently, the non-coding genome has gained prominence due to its critical role in development 22 and disease. Here, we have re-purposed the Ac/Ds maize transposition system to reliably screen 23 and efficiently characterise zebrafish enhancers, with or without germline propagation. We 24 further utilised the system to stably express guide RNAs in microinjected embryos enabling 25 tissue-specific CRISPR/dCas9-interference (CRISPRi ) knockdown of lncRNA and enhancer 26 activity without disrupting the underlying genetic sequence. Our study highlights the utility of 27 Ac/Ds transposition for transient epigenome modulation of non-coding elements in zebrafish. 28 102 non-coding genomic elements. By harnessing its reliability and efficiency for somatic 103 integration, the toolkit can be robustly used either in transient and/or to complement 104 transgenic-based methods. 105 Results and Discussion 106 Ac/Ds transposition is more effective than Tol2 for transient integration of 107 transgenes in F 0 zebrafish embryos. 108 As a first step in re-purposing the maize Ac/Ds transposition system for zebrafish, we generated 109 a new enhancer/reporter construct (pVC-Ds-E1b:eGFP-Ds) for efficient and reproducible in 110 vivo testing of enhancer activity. The construct consists of the eGFP expression cassette under 111 the control of the zebrafish E1b minimal promoter (Becker et al., 2016) flanked by Ds elements 112 6for integration into the genome (Emelyanov et al., 2006, Emelyanov and Parinov, 2008), and 113 features a multiple cloning site for cloning enhancer sequences to test upstream of the minimal 114 promoter (Fig.1A). We compared the efficiency and efficacy of Ac/Ds-and Tol2-mediated 115 integration (Kawakami, 2004) by transiently expressing a previously predicted zebrafish 116 enhancer for pax3a with strong activity (Trinh et al., 2017, Gavriouchkina et al., 2017) ("pax3a 117 enhancer"). Ac/Ds and Tol2 versions of the pax3a enhancer were microinjected into 118 Gt(FoxD3:mCherry) ct110aR transgenic embryos (Hochgreb-Hägele and Bronner, 2013) together 119with 24 pg Ac or 50-80 pg Tol2 mRNA, respectively. We observed a clean and tissue-specific 120 pattern of eGFP expression in neural crest cells at the neural plate border with 30 pg of the 121 Ac/Ds vector, a result that could only be recapitulated with 150 pg of Tol2 vector (Fig.1A), 122 indicating higher somatic integration efficiency by Ac/Ds as previously reported (Vrljicak et al., 123 2016). To quantify this observation, we collected embryos injected with 30 pg of the Ac/Ds or 124 Tol2 pax3a enhancer for GFP immunohistochemistry (IHC) together with Hoechst-staining of 125 nuclei, followed by confocal imaging and Imaris image analysis (Supp. Fig.1, Materials & 126 Methods). Ac/Ds-injected embryos demonstrated up to 9-fold increase in GFP + /Hoechst + 127 signal compa...